As 2024 is ending, a final look back at a busy year in investigations: For @bmj_latest, @Tilana145 , Simon Wörpel, Edgar Zanella Alvarenga and I mapped the oil industry’s financial ties to medical research. (German for @SZ : https://t.co/jaoOpoQuRt) https://t.co/JzQOiljsMk
Great to see my investigation into mounjaro in the papers and covered on @bbc5live and @BBCBreakfast today
Two months after the roll-out less than half of England has access to the weight-loss jab through their GP
Read the full story here @bmj_latest 👇 https://t.co/n5Odbl31Ec
🔔Hiring callout! The Examination is seeking an editor with experience executing impactful stories to lead our food and polluting industries reporting teams.
⏰Full-time, remote position
💰$130K- $150K
For more details on our team and how to apply: https://t.co/9ZvO7CTiQ4
How safe are health tests on UK supermarket shelves? Studies suggest that some commercially available health tests are inaccurate and unsuitable for public use.
@rebeccacoombes@Garethiacobucci@hristio report
https://t.co/EhlFUhy5g9
I'm looking for doctors to write about how they dealt with being humiliated by a colleague for a @bmj_latest careers article
Get in touch - [email protected] or DMs open
#MedTwitter
Studies suggest that some commercially available health tests are inaccurate and unsuitable for public use. Is regulation adequately protecting consumers?
@rebeccacoombes@Garethiacobucci@hristio report
https://t.co/EhlFUhy5g9
"Grünenthal taught sales representatives to promote the drug to doctors as less likely to cause dependence"
New World Report—Misleading marketing claims fuel tapentadol prescriptions: https://t.co/Dllm7oHVzv
Very happy to present our collaborative investigation on opioids in a Netzwerk Recherche online event together with the great @MariaChristoph. Check out our recent @examinationnews publication on opioid producer Grünenthal and its drug tapentadol:
https://t.co/wp2vZaTPqb
Today @examinationnews & partners reveal that Grünenthal, the German pharma company notorious for the 1960s thalidomide scandal, has been promoting its latest opioid in misleading ways. Prescriptions are surging in many countries. Read in @TelGlobalHealth https://t.co/yRUL233MQj
The year started with another collaboration with Piotr Ozieranski and Shai Mulinari, in which we showed that the UK’s pharmaceutical industry self governing body has developed a major backlog in handling complaints over drug companies’ marketing practices https://t.co/1xekAfGk1h
As 2024 is ending, a final look back at a busy year in investigations: For @bmj_latest, @Tilana145 , Simon Wörpel, Edgar Zanella Alvarenga and I mapped the oil industry’s financial ties to medical research. (German for @SZ : https://t.co/jaoOpoQuRt) https://t.co/JzQOiljsMk
Turning to the alcohol industry, @madlendavies and I showed how it is involved in drinking awareness campaigns in schools and universities https://t.co/UBpBFhoIfZ
🚨Fossil fuel companies have strong links to medical research. Over the past 6 years, more than 180 medical articles have acknowledged this industry's funding, and another 1000 articles feature authors who worked for a fossil fuel company or similar.
https://t.co/DmUirKvhkW
An investigation by The BMJ shows the extent of the fossil fuel industry’s involvement in medical research, leading to fresh calls for academics and publishing companies to cut ties with such companies.
@hristio reports
https://t.co/N4qYwTroLQ